Literature DB >> 17314014

Antimicrobial resistance profile of Actinobacillus pleuropneumoniae and Actinobacillus porcitonsillarum.

Denise Matter1, Alexandra Rossano, Sandra Limat, Lorianne Vorlet-Fawer, Isabelle Brodard, Vincent Perreten.   

Abstract

A total of 83 Actinobacillus pleuropneumoniae and 58 Actinobacillus porcitonsillarum strains collected from slaughtered pigs in Switzerland were screened for susceptibility to 20 antimicrobial agents by MIC determinations. Resistance to sulfamethoxazole, the combination sulfamethoxazole-trimethoprim, tiamulin, tilmicosin, tetracycline, penicillin and ampicillin were found. A few A. porcitonsillarum isolates displayed decreased susceptibility to enrofloxacin. PCR analysis revealed the presence of the sul2 gene in approximately one-fifth of the sulfonamide-resistant A. pleuropneumoniae and A. porcitonsillarum isolates. The tetracycline-resistant A. pleuropneumoniae harbored tet(B) and tet(H), whereas the tetracycline-resistant A. porcitonsillarum isolates harbored the tet(B) gene. The penicillin and ampicillin-resistant A. pleuropneumoniae and A. porcitonsillarum harbored the bla(ROB-1) gene.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17314014     DOI: 10.1016/j.vetmic.2007.01.009

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  8 in total

1.  Granulomatous lymphadenitis associated with Actinobacillus pleuropneumoniae serotype 2 in slaughter barrows.

Authors:  Takemi Ohba; Tomoyuki Shibahara; Hideki Kobayashi; Ariko Takashima; Masataka Nagoshi; Masanori Kubo
Journal:  Can Vet J       Date:  2010-07       Impact factor: 1.008

2.  Identification of dfrA14 in two distinct plasmids conferring trimethoprim resistance in Actinobacillus pleuropneumoniae.

Authors:  Janine T Bossé; Yanwen Li; Stephanie Walker; Tom Atherton; Roberto Fernandez Crespo; Susanna M Williamson; Jon Rogers; Roy R Chaudhuri; Lucy A Weinert; Olusegun Oshota; Matt T G Holden; Duncan J Maskell; Alexander W Tucker; Brendan W Wren; Andrew N Rycroft; Paul R Langford
Journal:  J Antimicrob Chemother       Date:  2015-05-08       Impact factor: 5.790

3.  Transcriptional profiling of hilar nodes from pigs after experimental infection with Actinobacillus pleuropneumoniae.

Authors:  Shumin Yu; Zhicai Zuo; Hengmin Cui; Mingzhou Li; Xi Peng; Ling Zhu; Ming Zhang; Xuewei Li; Zhiwen Xu; Meng Gan; Junliang Deng; Jing Fang; Jideng Ma; Shengqun Su; Ya Wang; Liuhong Shen; Xiaoping Ma; Zhihua Ren; Bangyuan Wu; Yanchun Hu
Journal:  Int J Mol Sci       Date:  2013-11-29       Impact factor: 5.923

4.  Characterization of antimicrobial resistance genes in Haemophilus parasuis isolated from pigs in China.

Authors:  Yongda Zhao; Lili Guo; Jie Li; Xianhui Huang; Binghu Fang
Journal:  PeerJ       Date:  2018-04-09       Impact factor: 2.984

5.  Exposure to benzylpenicillin after different dosage regimens in growing pigs.

Authors:  Marie Sjölund; Carl Ekstrand; Per Wallgren; Ulf Bondesson; Märit Pringle; Björn Bengtsson
Journal:  Acta Vet Scand       Date:  2020-09-17       Impact factor: 1.695

6.  Evidence for Establishing the Clinical Breakpoint of Cefquinome against Haemophilus Parasuis in China.

Authors:  Kun Mi; Da Sun; Mei Li; Haihong Hao; Kaixiang Zhou; Zhenli Liu; Zonghui Yuan; Lingli Huang
Journal:  Pathogens       Date:  2021-01-22

7.  A Combinatorial Vaccine Containing Inactivated Bacterin and Subunits Provides Protection Against Actinobacillus pleuropneumoniae Infection in Mice and Pigs.

Authors:  Lijun Zhang; Wentao Luo; Ruyue Xiong; Haotian Li; Zhiming Yao; Wenxiao Zhuo; Geng Zou; Qi Huang; Rui Zhou
Journal:  Front Vet Sci       Date:  2022-06-07

8.  Pharmacokinetic/Pharmacodynamic Integration to Evaluate the Changes in Susceptibility of Actinobacillus pleuropneumoniae After Repeated Administration of Danofloxacin.

Authors:  Longfei Zhang; Zheng Kang; Lihua Yao; Xiaoyan Gu; Zilong Huang; Qinren Cai; Xiangguang Shen; Huanzhong Ding
Journal:  Front Microbiol       Date:  2018-10-10       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.